; Whereas the United States PEPFAR program remains the largest commitment in history by any country to combat a single disease; Whereas 25,000,000 lives have been saved through PEPFAR; Whereas, as of September 30, 2022, PEPFAR has supported treatment for more than 20,000,000 people, and has enabled 5,500,000 infants of mothers living with HIV to be born HIV-free; Whereas in fiscal year 2021, PEPFAR directly supported HIV testing and counseling for 64,700,000 people; Whereas the Global Fund to Fight AIDS, Tuberculosis and Malaria was launched in 2002, and, as of 2022, has helped provide antiretroviral therapy to approximately 24,500,000 people living with HIV/AIDS and to 710,000 pregnant women to prevent the transmission of HIV/AIDS to their children, saving an estimated 59,000,000 lives; Whereas the United States is the largest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and every $1 contributed by the United States leverages an additional $2 from other donors, as required by law; Whereas, with United States leadership, global partners pledged record amounts to combat infectious diseases at the seventh replenishment of the Global Fund to Fight AIDS in September 2022; Whereas considerable progress has been made in the fight against HIV/AIDS, including a nearly 40-percent reduction in new HIV infections, a nearly 60-percent reduction in new HIV infections among children, and a 50-percent reduction in the number of AIDS-related deaths between 2010 and 2022; Whereas approximately 29,800,000 people had access to antiretroviral therapy in 2022, compared to only 7,800,000 people who had access to such therapy in 2010; Whereas research funded by the National Institutes of Health found that HIV treatment not only saves the lives of people living with HIV, but people living with HIV on effective antiretroviral therapy and who are durably virally suppressed cannot sexually transmit HIV, proving that HIV treatment is prevention